Mesoblast Ltd
ASX:MSB

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
ASX:MSB
Watchlist
Price: 1.65 AUD 1.85% Market Closed
Market Cap: 2.1B AUD

Intrinsic Value

The intrinsic value of one MSB stock under the Base Case scenario is hidden AUD. Compared to the current market price of 1.65 AUD, Mesoblast Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

MSB Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Mesoblast Ltd

MSB
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MSB cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Mesoblast carries heightened regulatory risk after repeated FDA delays and requests for more data on its lead candidate, Remestemcel-L, which could further prolong commercialization timelines and deplete financial resources.

Bull Theses

If Remestemcel-L achieves FDA approval for pediatric steroid-refractory acute graft-versus-host disease, Mesoblast could secure a first-mover advantage in cell-based therapies for this life-threatening indication.

Show More Less
How do you feel about MSB?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Mesoblast Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mesoblast Ltd

Current Assets 69.7m
Cash & Short-Term Investments 37.7m
Receivables 3m
Other Current Assets 29m
Non-Current Assets 583.6m
Long-Term Investments 1.2m
PP&E 6.2m
Intangibles 574.9m
Other Non-Current Assets 1.3m
Efficiency

Free Cash Flow Analysis
Mesoblast Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Mesoblast Ltd

Revenue
5.7m USD
Cost of Revenue
5.8m USD
Gross Profit
11.4m USD
Operating Expenses
-91.6m USD
Operating Income
-80.2m USD
Other Expenses
-23.2m USD
Net Income
-103.4m USD
Fundamental Scores

MSB Profitability Score
Profitability Due Diligence

Mesoblast Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Declining ROIC
Declining ROE
Negative 1-Year Revenue Growth
hidden
Profitability
Score

Mesoblast Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

MSB Solvency Score
Solvency Due Diligence

Mesoblast Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
hidden
Solvency
Score

Mesoblast Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MSB Price Targets Summary
Mesoblast Ltd

Wall Street analysts forecast MSB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MSB is 3.42 AUD with a low forecast of 2.42 AUD and a high forecast of 4.52 AUD.

Lowest
Price Target
2.42 AUD
47% Upside
Average
Price Target
3.42 AUD
107% Upside
Highest
Price Target
4.52 AUD
174% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Mesoblast Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for MSB is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Ownership

MSB Insider Trading
Buy and sell transactions by insiders

MSB News

Other Videos
What is the Intrinsic Value of one MSB stock?

The intrinsic value of one MSB stock under the Base Case scenario is hidden AUD.

Is MSB stock undervalued or overvalued?

Compared to the current market price of 1.65 AUD, Mesoblast Ltd is hidden .

Back to Top